A. Schulman recorded fiscal first-quarter earnings down 13.2% year-on-year (YOY), to $11.8 million, on sales up 4.5%, to $540.6 million. Adjusted earnings totaled 50 cts/share, slightly ahead of analystsâ€™ consensus estimate of 49 cts/share, as reported by Thomson Reuters (New York). A. Schulmanâ€™s fiscal first-quarter ended on 30 November. The company reiterated its full-year 2013 earnings guidance of $2.14-$2.19/share. In Europe, the Middle East and Africa (EMEA), sales were down 0.4% YOY, to $351.5 million, while operating income fell 16.1%, to $16.1...
Access is for Chemweek 24/7 PLUS Members ONLY
This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information.
Forgot your user ID or password? Click here to have it sent to you.